Umesh T. Sankpal

University of North Texas — United States

Medicine · Health Sciences

21h-index1.7kcitations107works0.02yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Inflammatory mediators and NSAID effects(16), Health, Medicine and Society(16), Hermeneutics and Narrative Identity(16), Aging, Elder Care, and Social Issues(16), Cancer, Lipids, and Metabolism(13)

Publications107 total

Abstract 7054: Mithramycin and chemotherapy combination induces apoptosis in Ewing sarcoma cells by upregulating reactive oxygen species and associated pathways
Cancer Research·2025
Abstract 373: Comparison of the anti-cancer mechanism of tolfenamic acid and its copper (II) complex
Cancer Research·2025
Abstract 6255: Anti-proliferative effect of two copper complexes against medulloblastoma cells
Cancer Research·2023· 2 cited
Abstract 6733: Targeting Sp1 in Ewing sarcoma: a multi-approach method for the utilization of mithramycin
Cancer Research·2023
Abstract 1901: Analysis of the survivin expression in breast tumor tissue from black and white cancer patients
Cancer Research·2023
Metal Oxide Doped Egg Shell-Fly Ash Composite: An Effective Catalyst for Transesterification of Waste Oil
ECS Transactions·2022
List of contributors
Elsevier eBooks·2022
Association of specificity protein 1 with hepatocellular carcinoma
Elsevier eBooks·2022
Cytotoxic Activities of Aspergillin PZ and Trichoderone B from an Isolate of Aspergillus flavipes sp. Against NCI-60 Human Tumor Cell Lines
Records of Natural Products·2021Open Access
Evaluating the Anti-Proliferative Effects of Less Toxic Agents Against High-Risk Neuroblastoma Cells
2021
Targeted Molecular Therapeutic Options for Hepatocellular Carcinoma
Critical Reviews™ in Oncogenesis·2020· 5 citedOpen Access
Anti-proliferative activity of clotam and copper-clotam against T-cell Acute lymphoblastic leukemia cell line CCRF-CEM
2020
Next generation sequencing and functional pathway analysis to understand the mechanism of action of copper-tolfenamic acid against pancreatic cancer cells
Process Biochemistry·2019· 7 citedOpen Access
Abstract 2881: Antiproliferative effect of copper complex of clotam in neuroblastoma cell lines
Cancer Research·2019
Abstract 2881: Antiproliferative effect of copper complex of clotam in neuroblastoma cell lines
Tumor Biology·2019Open Access
Abstract 2972: Effect of novel copper-tolfenamic acid complex on medulloblastoma cells
Experimental and Molecular Therapeutics·2019
Abstract 2605: Mithramycin enhances the efficacy of etoposide in Ewing sarcoma cells and a mouse xenograft tumor model
Molecular and Cellular Biology / Genetics·2019
Abstract 2972: Effect of novel copper-tolfenamic acid complex on medulloblastoma cells
Cancer Research·2019
Abstract 2605: Mithramycin enhances the efficacy of etoposide in Ewing sarcoma cells and a mouse xenograft tumor model
Cancer Research·2019
Abstract 4811: Functional pathway analysis in pancreatic cancer cells treated with a novel anti-cancer agent, copper-tolfenamic acid
Cancer Research·2019
page 1 of 6Next →

Frequent Co-authors

Riyaz Basha(33), Nagendra S. Ningaraj(8), Pius Maliakal(8), Myrna Hurtado(7), Don Eslin(7), Divya Khaitan(6), Sarah F. Connelly(6), Jamboor K. Vishwanatha(6), Robert M. Sutphin(6), W. Paul Bowman(6), Maen Abdelrahim(5), Chris M. Lee(5), Jerry W. Simecka(5), Alvin A. Holder(5), Keith D. Robertson(4), Sagar Shelake(4), Jaya Chhabra(4), Deondra T. Brown(4), Raj K. Gurung(4), Trib S. Vats(4)